Durham, NC, United States of America

Elizabeth Gottlin

This inventor holds 5 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Duke University. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth Gottlin. Retrieved from https://idiyas.com/inventor/elizabeth-gottlin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Elizabeth Gottlin

Introduction

Elizabeth Gottlin is a prominent inventor based in Durham, NC (US), known for her significant contributions to the field of biomedical research. With a total of five patents to her name, she has made remarkable strides in the development of therapies targeting complement factor H.

Latest Patents

Among her latest patents are innovative inhibitors of complement factor H. These include anti-CFH antibodies and small molecules, along with methods for utilizing these inhibitors effectively. Her work focuses on methods of inhibiting complement factor H (CFH) by administering an antibody that binds to CFH, showcasing her commitment to advancing medical science.

Career Highlights

Elizabeth Gottlin is affiliated with Duke University, where she continues to push the boundaries of research and innovation. Her work has not only contributed to the academic community but has also paved the way for potential therapeutic applications in various medical conditions.

Collaborations

She has collaborated with esteemed colleagues such as Edward F Patz, Jr. and Michael J Campa, further enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Elizabeth Gottlin's innovative work in the field of complement factor H inhibitors exemplifies her dedication to advancing medical research. Her contributions are significant and continue to inspire future innovations in the biomedical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…